Close Menu
Joseph Keegan has been named president and CEO of ForteBio, effective Sept. 24. Keegan joins the firm from Molecular Devices, where he served as president and CEO until the firm was acquired earlier this year by MDS. Keegan replaces founding CEO Winnie Wan, who will continue to serve on ForteBio’s board of directors.
 

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.